Imipenem/relebactam

Edina Avdic, Pharm.D.
Pediatric Dosing Author: Lisa Hutchins, Pharm.D.
Imipenem/relebactam is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please log in or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

Abdominal MassAbdominal Mass

metoprololmetoprolol

Hepatic AbscessHepatic Abscess

Inguinal HerniaInguinal Hernia

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Infections caused by susceptible Gram-negative bacteria for patients who have limited or no alternative treatment options, who are ≥ 18 y/o; approval of these indications is based on limited clinical safety and efficacy data.
    • Treatment of complicated urinary tract infections, including pyelonephritis (cUTI)
    • Complicated intra-abdominal infections (cIAI)

NON-FDA APPROVED USES

  • MDR infections including bacteremia, pneumonia, osteomyelitis

-- To view the remaining sections of this topic, please log in or purchase a subscription --

INDICATIONS

FDA

  • Infections caused by susceptible Gram-negative bacteria for patients who have limited or no alternative treatment options, who are ≥ 18 y/o; approval of these indications is based on limited clinical safety and efficacy data.
    • Treatment of complicated urinary tract infections, including pyelonephritis (cUTI)
    • Complicated intra-abdominal infections (cIAI)

NON-FDA APPROVED USES

  • MDR infections including bacteremia, pneumonia, osteomyelitis

There's more to see -- the rest of this entry is available only to subscribers.